Max Healthcare Institute (MAXHEALTH, Healthcare) was incorporated on 18 June 2001. This page shows its birth chart, its dasha periods since listing and how the share moved in each.
Lagna Karka, lagna lord Chandra in the 10th house. Moon in Mesha, Bharani pada 3.
Max Healthcare Institute is a company whose chart rests on work and steady execution. Mangal, the planet of drive, rules both the house of career and the house of success here, and sits in its own sign. That is why a hospital chain built on bed capacity, specialist doctors and disciplined expansion has grown the way it has. Revenue is ₹9,146 crore over the latest twelve months, and net profit is ₹1,381 crore.
The one idea this reading keeps returning to is simple. When the planets running the company's period support work and gains, the business and the share move together and well. When the period belongs to a planet that is weak in this chart, growth continues but the share loses its pace. Shukra, the planet of comfort and spending, is one of the weakest here, and its long period matched the hardest stretch the share has seen.
This reading follows the company from its incorporation on 18 June 2001 to today, period by period. The hour of incorporation is not on record, so the houses are indicative while the Moon and the dashas are firm. The chart did not call every move, and where the share went against it, the sections say so plainly.
The chart is read here in brief. The hour of incorporation is not on record, so the houses are indicative, while the Moon and the dasha periods are firm.
The first placement is Mangal, the planet of energy and action. It rules both the house of career and the house of success, and it sits in its own sign. That is the strongest feature of the chart. It fits a company that keeps building hospitals and filling beds. Revenue is up 20.3% on the year to September 2026, close to the median Healthcare company at 22.5%, and the Q2 press release put quarterly revenue at Rs 3,219 crore, up 20%.
The second placement is Shani, the planet of discipline, in the house of gains, in a friendly sign. It steadies the company's earnings and its balance sheet. Debt is 0.33 times equity, operating profit covers interest 7.8 times, and operating cash is 1.13 times reported profit. In October 2026 CARE Ratings upgraded the company to AA+, the high safety grade.
The weak spot is Guru, the planet of expansion and good fortune. It sits in the house of loss and outflow, in an enemy sign, and is burnt by the Sun's closeness. Shukra, the planet of comfort and money, is also weak. This explains why the company's profit does not keep pace with its growth. Profit is down 15.5% on the year, against a rise of 15.3% for the median peer, and the long Moon–Venus period was the worst in the share's history.
The same pressure shows in regulators' attention. The company filed 10 legal or tax matters in the past year, and SEBI penalties were recorded on 29 October and 3 November 2026. The top team also changed often, with 6 management change filings in the year. Strength in work, weakness in margins and rules: that is the chart's pattern.
The Moon major period began with the NSE listing in August 2020 and runs to November 2026. Across it the share went from Rs 111 to Rs 947, a gain of 753%. Four of the six sub-periods beat the Nifty by a wide margin. The last two, from December 2024, fell behind it.
The reason is simple. Chandra, the Moon, rules the first house, the house of the company's own identity, and sits in the 10th house of work and standing. A Moon period therefore rewards visible operating strength, and that is what hospital occupancy and new beds delivered here.
The record backs this. The share's highest close was Rs 1,298 in July 2025, and the deepest point afterwards was Rs 815 in October 2026. The business itself stayed sound through the weak patch: revenue is up 20.3% on the year to September 2026, and debt is only 0.33 times equity. What cooled was the share, not the hospitals.
Each sub-period below shows a different kind of stretch and why the chart reads it that way.
From August 2020 to May 2021 the share rose 97%, against 29% for the Nifty. This was the best stretch in the share's history. The company had just listed, on 20 August 2020, after the demerger and merger with Radiant, and the market welcomed a cleaner, hospital-only business.
The reason is Guru, the planet of expansion, which ruled this sub-period. It rules the 6th and 9th houses, and sits in the 12th house of distant matters and losses. Guru is weak in this chart, so the chart does not promise ease. Yet a new listing is a 9th-house event, the house of fortune, and fortune did favour it here.
For an investor, this tells you the company's first public chapter began with strong goodwill. The lesson is that Max Healthcare tends to be rewarded fast when its structure is simple and its hospitals are full. The share here ran well ahead of what its weak Guru would suggest, so the chart did not fully explain the pace; the post-listing mood did much of the work.
From May 2021 to December 2022 the share rose 96%, against 27% for the Nifty. It was not smooth. At its worst point inside the period the share was down 26%. On 20 April 2022 it jumped 10% in a single day, the sharpest move of the stretch.
Shani, the planet of discipline and delay, ruled this sub-period. It sits in the 11th house of gains, in a friendly sign, and is one of the chart's three strongest planets. That explains gains that came by slow, hard work rather than a sudden rush. Shani also rules the 8th house of sudden shocks, which fits the deep dip and the single violent day.
For an investor, this tells you the company earns its gains through patient capacity building and bears real drawdowns on the way. Calendar 2022 ended almost flat, down 0.8%, because the early gains were given back. The chart read the period correctly overall, but the share's path inside it was rougher than the final number suggests.
From December 2022 to May 2024 the share rose 89%, against 19% for the Nifty. Calendar 2023 closed 56.4% higher at Rs 683, with the Nifty up 20%. On 13 September 2023 the company filed a change in senior management.
Budh, the planet of trade and communication, ruled this sub-period. It rules the 3rd house of effort and the 12th house of spending, and sits in its own sign, which makes it one of the strongest planets here. It is also combust, burnt by the Sun's closeness, so the strength works through the team rather than through one person. A leadership change inside this period fits that picture.
For an investor, this tells you the company absorbs changes in senior management without losing pace. The handover in September 2023 came mid-climb and the share kept rising. The chart matched the outcome well here: effort and execution, the 3rd-house themes, paid off for the business.
From May 2024 to December 2024 the share rose 45%, against 12% for the Nifty. Calendar 2024 ended 64.7% higher at Rs 1,125, the strongest full year on record apart from 2021. This came in a short eight-month window.
Ketu, the shadow planet of detachment, ruled this sub-period. It sits in the 6th house of competition and service, which suits a hospital business that wins by treating more patients than its rivals. Ketu gives no results of its own and acts through its dispositor Guru, so the rise carried the earlier momentum forward rather than starting something new.
For an investor, this tells you the business was running on solid ground. The record today shows operating cash at 1.13 times reported profit, and customers pay in about 50 days. That is a business turning profit into cash. The share rose on that strength, and the chart's detachment theme only showed later, as the pace faded in the next period.
From December 2024 to August 2026 the share fell 14%, against a 2% fall for the Nifty. At its worst point inside the period it was down 28%. The share made its highest close of Rs 1,298 in July 2025, then slid to Rs 815 in October 2026. Calendar 2025 lost 7.3% while the Nifty gained 10.5%, so the lag was clear.
Shukra, the planet of comfort and money, ruled this sub-period. It rules the 4th house of assets and the 11th house of gains, but it is one of the chart's two weakest planets and is debilitated in the finer divisional charts. Weak Shukra means gains came with friction and the market grew less generous.
The business did not stumble. Revenue grew and debt stayed low. Profit is down 15.5% on the year to September 2026, while peers' profit rose 15.3%, so earnings quality, not sales, was the soft spot. For an investor, this tells you the company can grow fast and still disappoint on profit. The chart read this stretch as the hardest, and the share agreed.
From August 2026 to November 2026 the share fell 6%, while the Nifty rose 3%. The business reported its September quarter on 30 October 2026: revenue Rs 3,219 crore, up 20%, and profit Rs 448 crore, up 10%. CARE Ratings upgraded the company to AA+ on 9 October 2026, with a stable outlook.
Surya, the Sun, ruled this sub-period. It rules the 2nd house of money and sits in the 12th house of expense, joined by Guru, Budh and Rahu. Money earned is therefore pressed by outgoings, which fits profit growing at half the pace of revenue. SEBI penalty filings on 29 October and 3 November added to the heavy legal tally of 10 filings in the year.
For an investor, this tells you the company is strong on credit and sales but carries regulatory noise. The share fell even as results and the rating improved, so the chart's cautious reading held while the business news was good. It is a short window, and it shows the company's profit growth, not its hospitals, was what lagged.
The facts name three turning points for Max Healthcare: the incorporation, the listing and a change at the top. Each fell under a different planetary chain, and two of the three share one recurring planet, Chandra, the Moon. That is where the pattern lies.
Chandra comes first because it is the lord of the first house, the house of the company's own identity, and it sits in the tenth house of public standing. Its period carried the 20 August 2020 listing, which came after the demerger and merger with Radiant. The chain that day was Chandra–Guru–Ketu. It was a moment of public arrival, which is what a tenth-house Chandra delivers. Ketu, the planet of detachment, sits in the sixth house and fits a day when old structures were shed and new ones formed.
The same Chandra period held the change in senior management personnel on 13 September 2023, under Chandra–Budh–Mangal. Budh, Mercury, rules the third and twelfth houses and sits combust in the twelfth, which is the house of exits and endings. Mangal, Mars, is the yogakaraka, the chart's most useful planet, and rules the tenth house of leadership. So a change in people at the top is what this chain brings. It also explains why the filings show six management-change filings in the last year. Leadership moves are a recurring habit here, not a one-off.
Guru, Jupiter, is the second planet that recurs. The incorporation on 18 June 2001 fell in Shukra–Guru–Guru. The facts do not record how that day went, so nothing more is claimed for it. Guru rules the sixth and ninth houses and is the weakest planet in the chart, sitting combust in the twelfth. It also appeared as the sub-lord on listing day. A start and a listing both under Guru fit a company whose growth came through restructuring and absorbing other businesses, not through a smooth, single path.
The takeaway is plain. Chandra's period gave this company its public debut and its leadership change, and the share rose 753% across that period, from Rs 111 to Rs 947. The same weak Guru that opened the chart also sat behind the listing. For an owner, the lesson is that the big structural moves here come in groups, and a change in management has usually come alongside a change in the company's shape.
The record sorts the periods into two camps. Those run by Jupiter, Saturn and Mercury lifted both the business and the share. Those run by Venus and the Sun pressed on them.
The Moon-Jupiter stretch from Aug 2020 to May 2021 gave +97% against +29% for the Nifty. Moon-Saturn followed, with +96% to Dec 2022, and Moon-Mercury added +89% to May 2024. Saturn and Mercury are two of the chart's three strongest planets, and the share ran well ahead of the market in each. Moon-Ketu then added 45% to Dec 2024. Four periods in a row gave the share between three and five times the Nifty's gain.
Venus is the chart's weakest planet, and its period behaved that way. From Dec 2024 to Aug 2026 the share fell 14%, with a drop of 28% at the worst point. The Nifty lost only 2%. The Sun period since Aug 2026 has given another 6% fall while the Nifty rose 3%.
The present record bears this out only in part. Revenue is up 20.3% on the year and the latest quarter reached ₹3,219 crore. Yet profit is down 15.5% against a peer median gain of 15.3%, so the pressure of the weak periods shows in earnings, not in sales. The business itself stays sound: debt is 0.33 times equity, interest is covered 7.8 times, and CARE Ratings upgraded it to AA+ on 9 October 2026. Regulatory penalties filed by SEBI on 29 October and 3 November 2026 are a sign of the same strain.
The coming periods, with their dates and what each holds for the business, are read in the full reading.
Max Healthcare Institute was incorporated on 18 June 2001. Its kundali is cast for that date.
Max Healthcare Institute's chart rises in Karka, with its lord Chandra in the 10th house. The Moon is in Mesha, Bharani pada 3.
Max Healthcare Institute is in the Chandra mahadasha and the Surya antardasha, which runs until 13 February 2027. The sub-period inside it, Shani, ends on 8 December 2026.
Max Healthcare Institute listed on the National Stock Exchange on 21 August 2020.
Max Healthcare Institute is in Healthcare. In the classical scheme the sector is ruled by Ketu for research-led pharma, with Rahu for chemicals. Its strength in transit sets the sector's weather; Max Healthcare Institute's own chart shows how the company is built for it.
No. GrahaEdge reads the company's chart and history. It gives no share-price targets and no buy, sell or hold calls.